Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions.
Open accessThe DOI matches its OpenAlex record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Tobacco use is the largest risk factor for lung cancer and many lung cancer patients still smoke at the time of diagnosis. Although clinical practice guidelines recommend that all patients receive evidence-based tobacco treatment, implementation of these services in oncology practices is inconsistent and inadequate. Multidisciplinary lung cancer treatment programs offer an ideal environment to optimally deliver effective smoking cessation services. This article reviews best practice recommendations and current status of tobacco treatment for oncology patients, and provides recommendations to optimize delivery of tobacco treatment in multidisciplinary practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Free, C., Phillips, G., Galli, L., Watson, L., Felix, L., Edwards, P., Patel, V., & Haines, A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001362 · Cited by 1,766 · cited 1×
“Although not yet evaluated specifically for lung cancer populations, mobile technology, such as text messaging services and smoking cessation “apps” show considerable promise for smoking cessation (104,105).”
BackgroundParsons, A., Daley, A., Begh, R., & Aveyard, P. (2010) · BMJ · doi:10.1136/bmj.b5569 · Cited by 696
iPhone Apps for Smoking Cessation
Abroms, L. C., Padmanabhan, N., Thaweethai, L., & Phillips, T. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.10.032 · Cited by 365 · cited 1×
“Although not yet evaluated specifically for lung cancer populations, mobile technology, such as text messaging services and smoking cessation “apps” show considerable promise for smoking cessation (104,105).”
BackgroundSchroeder, S. A., & Morris, C. D. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103701 · Cited by 349 · cited 1×
“Smoking is associated with a lower level of education and lower socioeconomic status (91,92), higher rates of mental health disorders (93,94), higher rates of substance and alcohol abuse (95), and stigmatization associated with smoking or a lung cancer diagnosis (96).”
BackgroundA systematic review of the impact of stigma and nihilism on lung cancer outcomes
Chambers, S. K., Dunn, J., Occhipinti, S., Hughes, S., Baade, P., Sinclair, S., Aitken, J., Youl, P., & O’Connell, D. L. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-184 · Cited by 258 · cited 1×
“Smoking is associated with a lower level of education and lower socioeconomic status (91,92), higher rates of mental health disorders (93,94), higher rates of substance and alcohol abuse (95), and stigmatization associated with smoking or a lung cancer diagnosis (96).”
BackgroundComparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics
Smith, S. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.426 · Cited by 132
Hanna, N., Mulshine, J., Wollins, D. S., Tyne, C., & Dresler, C. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.8932 · Cited by 125 · cited 15×
“There are several excellent recent reviews that have discussed pharmacotherapy and evidence-based methods for cessation support (33,50,53,76,82,84,87), and we will defer much of this discussion to these reviews and guidelines.”
BackgroundInfluentialWestmaas, J. L., Newton, C. C., Stevens, V. L., Flanders, W. D., Gapstur, S. M., & Jacobs, E. J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3088 · Cited by 124 · cited 1×
“Principles of follow-up and relapse prevention are also discussed, which is highly applicable to cancer patients who are at risk for restarting tobacco use after a cancer diagnosis and treatment (33,50,80).”
Background
Cited by
Scientific Advances in Lung Cancer 2015
Tsao, A. S., Scagliotti, G. V., Bunn, P. A., Carbone, D. P., Warren, G. W., Bai, C., de Koning, H. J., Yousaf-Khan, A. U., McWilliams, A., Tsao, M. S., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.03.012 · Cited by 284
“have to be difficult and can be tailored to patient- and institution-specific needs.(6,13) Collectively, addressing tobacco use in conjunction with advances in lung cancer”
BackgroundSelf-citationAbdel-Rahman, O., Helbling, D., Schöb, O., Eltobgy, M., Mohamed, H., Schmidt, J., giryes, A., Mehrabi, A., Iype, S., John, H., et al. (2017) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12270 · Cited by 118
Considering systemic barriers to treating tobacco use in clinical settings in the United States
Rojewski, A. M., Bailey, S. R., Bernstein, S. L., Cooperman, N. A., Gritz, E. R., Karam-Hage, M. A., Piper, M. E., Rigotti, N. A., & Warren, G. W. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty123 · Cited by 85
Self-citation
Metadata
- Authors
- Warren, G. W., & Ward, K. D.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2015-08-01
- Volume
- 4
- Issue
- 4
- Pages
- 339-52
- OpenAlex
- W2173112342
- Cited by
- 35
- References
- 11
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. https://app.cochat.ai/papers/10.3978/j.issn.2218-6751.2015.07.15
- The paper
- Warren, G. W., & Ward, K. D. (2015). Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. PubMed. https://doi.org/10.3978/j.issn.2218-6751.2015.07.15
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.